ZYNERBA PHARMACEUTICALS, INC. Net Income
ZYNERBA PHARMACEUTICALS, INC. reported Net Income of -$10.78 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2023-06-30 was -$10.78M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$10.11M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$8.68M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2022-06-30 was -$9.85M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2022 was -$35.04M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2021 was -$37.31M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2020 was -$51.34M.
- ZYNERBA PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2019 was -$32.94M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$10.78M 10-Q · filed 2023-08-14 | -$20.90M 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | -$10.11M 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | -$35.04M 10-K · filed 2023-03-28 | |||
| 2022-09-30 | -$8.68M 10-Q · filed 2022-11-14 | -$18.53M derived: sum of 2 quarters · filed 2023-08-14 | -$27.02M derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-06-30 | -$9.85M 10-Q · filed 2023-08-14 | -$18.34M derived: sum of 2 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$8.49M 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | -$37.31M 10-K · filed 2023-03-28 | |||
| 2021-09-30 | -$10.58M 10-Q · filed 2022-11-14 | -$20.53M derived: sum of 2 quarters · filed 2022-11-14 | -$28.49M derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$9.95M 10-Q · filed 2022-11-14 | -$17.91M derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-03-31 | -$7.96M 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | -$51.34M 10-K · filed 2023-03-28 | |||
| 2020-09-30 | -$9.05M 10-Q · filed 2021-11-15 | -$29.38M derived: sum of 2 quarters · filed 2021-11-15 | -$41.72M derived: sum of 3 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$20.33M 10-Q · filed 2021-11-15 | -$32.67M derived: sum of 2 quarters · filed 2021-11-15 | ||
| 2020-03-31 | -$12.34M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | -$32.94M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$1.95M 10-Q · filed 2020-11-09 | -$13.08M derived: sum of 2 quarters · filed 2020-11-09 | -$22.23M derived: sum of 3 quarters · filed 2020-11-09 | -$30.02M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$11.14M 10-Q · filed 2020-11-09 | -$20.28M derived: sum of 2 quarters · filed 2020-11-09 | -$28.07M derived: sum of 3 quarters · filed 2021-03-10 | -$35.88M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$9.15M 10-Q · filed 2020-11-09 | -$16.94M derived: sum of 2 quarters · filed 2021-03-10 | -$24.74M derived: sum of 3 quarters · filed 2021-03-10 | -$36.75M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$7.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$15.60M derived: sum of 2 quarters · filed 2021-03-10 | -$27.60M derived: sum of 3 quarters · filed 2021-03-10 | -$39.91M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$7.81M 10-Q · filed 2019-11-06 | -$19.81M derived: sum of 2 quarters · filed 2019-11-06 | -$32.12M 10-Q · filed 2018-11-08 | -$40.24M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | -$12.01M 10-Q · filed 2019-11-06 | -$24.31M 10-Q · filed 2018-08-02 | -$32.43M derived: sum of 3 quarters · filed 2020-03-10 | -$40.74M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | -$12.31M 10-Q · filed 2019-11-06 | -$20.42M derived: sum of 2 quarters · filed 2020-03-10 | -$28.74M derived: sum of 3 quarters · filed 2020-03-10 | -$37.06M derived: sum of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | -$8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$16.43M derived: sum of 2 quarters · filed 2020-03-10 | -$24.75M derived: sum of 3 quarters · filed 2020-03-10 | -$32.01M 10-K · filed 2020-03-10 |
| 2017-09-30 | -$8.31M 10-Q · filed 2017-11-14 | -$16.63M derived: sum of 2 quarters · filed 2017-11-14 | -$23.89M 10-Q · filed 2017-11-14 | -$30.79M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | -$8.32M 10-Q · filed 2017-08-01 | -$15.58M 10-Q · filed 2017-08-01 | -$22.48M derived: sum of 3 quarters · filed 2019-03-11 | -$28.46M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | -$7.26M 10-Q · filed 2017-05-09 | -$14.16M derived: sum of 2 quarters · filed 2019-03-11 | -$20.14M derived: sum of 3 quarters · filed 2019-03-11 | -$26.37M derived: sum of 4 quarters · filed 2019-03-11 |
| 2016-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$12.88M derived: sum of 2 quarters · filed 2019-03-11 | -$19.11M derived: sum of 3 quarters · filed 2019-03-11 | -$23.39M 10-K · filed 2019-03-11 |
| 2016-09-30 | -$5.98M 10-Q · filed 2017-11-14 | -$12.21M derived: sum of 2 quarters · filed 2017-11-14 | -$16.49M 10-Q · filed 2017-11-14 | -$21.93M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$6.23M 10-Q · filed 2017-08-01 | -$10.51M 10-Q · filed 2017-08-01 | -$15.95M derived: sum of 3 quarters · filed 2017-08-01 | -$19.94M derived: sum of 4 quarters · filed 2017-08-01 |
| 2016-03-31 | -$4.28M 10-Q · filed 2017-05-09 | -$9.72M derived: sum of 2 quarters · filed 2017-05-09 | -$13.71M derived: sum of 3 quarters · filed 2017-05-09 | -$15.34M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$5.44M 10-K · filed 2016-03-14 | -$9.43M derived: sum of 2 quarters · filed 2016-11-14 | -$11.06M derived: sum of 3 quarters · filed 2016-11-14 | -$12.55M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$3.99M 10-Q · filed 2016-11-14 | -$5.62M derived: sum of 2 quarters · filed 2016-11-14 | -$7.11M 10-Q · filed 2016-11-14 | -$8.52M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$1.63M 10-Q · filed 2016-08-11 | -$3.12M 10-Q · filed 2016-08-11 | -$4.52M derived: sum of 3 quarters · filed 2016-08-11 | -$7.04M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$1.49M 10-Q · filed 2016-05-12 | -$2.90M derived: sum of 2 quarters · filed 2016-05-12 | -$5.41M derived: sum of 3 quarters · filed 2016-05-12 | -$6.92M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$1.40M 10-K · filed 2016-03-14 | -$3.92M derived: sum of 2 quarters · filed 2016-03-14 | -$5.43M derived: sum of 3 quarters · filed 2016-03-14 | -$5.67M 10-K · filed 2017-03-27 |
| 2014-09-30 | -$2.52M 10-K · filed 2016-03-14 | -$4.02M derived: sum of 2 quarters · filed 2016-03-14 | -$4.27M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$1.51M 10-K · filed 2016-03-14 | -$1.75M 10-Q · filed 2015-08-27 | ||
| 2014-03-31 | -$240.36K 10-K · filed 2016-03-14 | |||
| 2013-12-31 | -$636.79K 10-K · filed 2016-03-14 |